BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2159733)

  • 1. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of ACTH and endogenous-digitalis-like substances in human blood].
    Horký K; Schreiber V; Dvoráková J
    Sb Lek; 1989 Sep; 91(8-9):265-73. PubMed ID: 2562773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children.
    Stone J; Bentur Y; Zalstein E; Soldin S; Giesbrecht E; Koren G
    J Pediatr; 1990 Aug; 117(2 Pt 1):321-5. PubMed ID: 2166153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
    Lau BW; Valdes R
    Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
    Simon HB; Behrendt W; Stein T
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like substance(s) interfere(s) with serum estimations of the drug in cirrhotic patients.
    Nikou GC; Vyssoulis GP; Venetikou MS; Karga HI; Karoutsos KA; Toutouzas PK
    J Clin Gastroenterol; 1989 Aug; 11(4):430-3. PubMed ID: 2547866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile salts as endogenous digitalis like factors.
    Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
    Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
    Okamoto S
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
    Dodds HM; Norris RL; Johnson AG; Pond SM
    Ther Drug Monit; 1995 Feb; 17(1):68-74. PubMed ID: 7725380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous digitalis-like factors.
    Graves SW
    Crit Rev Clin Lab Sci; 1986; 23(3):177-200. PubMed ID: 3015491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.